Development of quinoline derivatives as dual EGFR/HDAC-2 inhibitors: design, synthesis, anticancer evaluation, and molecular dynamics simulations
Scientific Reports - Development of quinoline derivatives as dual EGFR/HDAC-2 inhibitors: design, synthesis, anticancer evaluation, and molecular dynamics simulations